Alterity Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Alterity Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Alterity Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alterity Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $4 | 2 | 2.00 |
2023-09-30 | $314 | 127 | 2.48 |